Must have provided written informed consent prior to any screening procedures. Male/female patients between 18 to 65 years of age at the time of informed consent who visit the clinic for having ERCP procedure. ERCP
Conditions
Interventions
Prucalopride 2 mg oral before ERCP 2 hour,Placebo 1 tab oral before ERCP 2 hour
Active Comparator Drug,Placebo Comparator Drug
Sponsors
Srinagarind Hospital Khonkaen University
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: Must have provided written informed consent prior to any screening procedures. Male/female patient between 18 to 65 years of age at the time of informed consent who visit the clinic for having ERCP procedure.
Exclusion criteria
Exclusion criteria: Suspected Intestinal obstruction or gastrointestinal leakage. Contradicted to anesthetic agents. Uncontrolled concomitant conditions; heart failure, hepatic failure, kidney failure, diabetes, hyperthyroidism or hypothyroidism. Taking antiplatelets at least 7 days prior to enrollment Taking warfarin at least 3 days prior to the enrollment Pregnant women Previous major surgery of gastrointestinal tract Allergy to Prucalopride Platelet normal
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Proportion of bowel ileus 90 min Film | — |
Secondary
| Measure | Time frame |
|---|---|
| Abdominal girt 30, 60 and 90 min Lenght | — |
Countries
Thailand
Contacts
Public ContactKawin Tangvoraphonkchai
Srinagarind hospital
Outcome results
None listed